Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandklinikken Stine Elkjær ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.3% 2.2% 4.2% 4.0% 3.3% 3.1% 6.1% 6.1%   Credit score (0-100)   56 66 47 49 54 56 39 39   Credit rating   BBB BBB BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,823 3,286 3,700 3,758 4,578 4,963 0.0 0.0   EBITDA   71.0 567 176 336 595 555 0.0 0.0   EBIT   -136 321 -72.2 87.1 359 316 0.0 0.0   Pre-tax profit (PTP)   -339.5 125.3 -268.8 -143.4 101.1 73.5 0.0 0.0   Net earnings   -267.7 95.8 -203.1 -123.0 76.6 55.1 0.0 0.0   Pre-tax profit without non-rec. items   -340 125 -269 -143 101 73.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   4,253 4,173 4,029 3,927 3,834 3,700 0.0 0.0   Shareholders equity total   1,546 1,586 1,270 1,032 991 924 749 749   Interest-bearing liabilities   3,102 3,617 2,598 2,957 2,662 2,605 721 721   Balance sheet total (assets)   6,635 6,493 6,200 6,018 5,899 5,718 1,470 1,470   Net Debt   3,084 3,603 2,575 2,947 2,654 2,593 721 721     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,823 3,286 3,700 3,758 4,578 4,963 0.0 0.0   Gross profit growth   0.0% 16.4% 12.6% 1.6% 21.8% 8.4% -100.0% 0.0%   Employees   6 6 6 6 6 7 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,635 6,493 6,200 6,018 5,899 5,718 1,470 1,470   Balance sheet change%   0.0% -2.1% -4.5% -2.9% -2.0% -3.1% -74.3% 0.0%   Added value   71.0 566.7 176.3 336.4 607.9 555.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   6,040 -430 -497 -457 -434 -479 -3,700 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -4.8% 9.8% -2.0% 2.3% 7.8% 6.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -2.0% 5.0% -1.1% 1.5% 6.1% 5.5% 0.0% 0.0%   ROI %   -2.6% 6.0% -1.4% 2.1% 8.5% 8.0% 0.0% 0.0%   ROE %   -17.3% 6.1% -14.2% -10.7% 7.6% 5.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   31.2% 24.4% 20.5% 17.2% 16.8% 16.2% 51.0% 51.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   4,346.0% 635.8% 1,459.9% 876.1% 446.2% 466.8% 0.0% 0.0%   Gearing %   200.7% 228.1% 204.6% 286.5% 268.6% 281.8% 96.2% 96.2%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   13.4% 6.0% 6.4% 8.4% 9.3% 9.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0   Current Ratio   0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0   Cash and cash equivalent   17.3 14.6 23.3 10.3 8.5 12.3 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -2,450.9 -2,193.1 -2,536.7 -2,674.5 -2,593.8 -2,548.0 -360.3 -360.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   12 94 29 56 101 79 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   12 94 29 56 99 79 0 0   EBIT / employee   -23 54 -12 15 60 45 0 0   Net earnings / employee   -45 16 -34 -21 13 8 0 0